Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

BACKGROUND: Risk-reducing salpingo-oophorectomy (RRSO) is widely used by carriers of BRCA1 or BRCA2 (BRCA1/2) mutations to reduce their risks of breast and ovarian cancer. To guide women and their clinicians in optimizing cancer prevention strategies, we summarized the magnitude of the risk reductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebbeck, Timothy R., Kauff, Noah D., Domchek, Susan M.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639318/
https://www.ncbi.nlm.nih.gov/pubmed/19141781
http://dx.doi.org/10.1093/jnci/djn442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639318/
https://www.ncbi.nlm.nih.gov/pubmed/19141781
http://dx.doi.org/10.1093/jnci/djn442

Ejemplares similares